Angiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer

Angiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer

Stereotactic body radiotherapy (SBRT) demonstrates excellent local control in early stage lung cancer, however a quarter of patients develop recurrence or distant metastasis. Transforming growth factor-beta (TGF-β) supports metastasis and treatment resistance, and angiotensin receptor blockade (ARB)...

Full description

Bibliographic Details
Main Authors: Lauren T. Maloney, Emile Latour, Yiyi Chen, Douglas Rice, Alison Grossblatt-Wait, Nima Nabavizadeh, Charles R. Thomas, Kristina H. Young, Joshua M. Walker, John Holland, Aaron J. Grossberg
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Cancer Biology & Therapy
Subjects:
non-small cell lung cancer (nsclc)
stereotactic body radiation therapy (sbrt)
angiotensin receptor blocker (arb)
tumor growth factor beta (tgf-β)
Online Access:http://dx.doi.org/10.1080/15384047.2022.2126250

Internet

http://dx.doi.org/10.1080/15384047.2022.2126250

Similar Items